At booth #115, Integer will spotlight its latest advancements in neuromodulation and next-generation miniaturized active implantable medical devices (AIMDs). These innovations are designed to ...

ReShape Lifesciences® announced the granting of an international patent for its Diabetes Neuromodulation technology from the Australian Patent Office, providing protection until April 12, 2039. This ...

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, ...

ImagineHealth and Vivatronix partner to bring SpineX’s neuromodulation technology to global markets, enhancing recovery for neurological condition patients. Patients have been waiting for a solution ...

ReShape Lifesciences has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent application on a new Diabetes Neuromodulation system utilizing its vagal nerve block ...

Using advanced precision neuromodulation technology, Kautz and the MUSC team are able to apply the latest imaging techniques to identify specific dysfunctional neural circuits. They then use advanced ...

IRVINE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences (RSLS) ® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the ...

IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company ...

(BPT) - New precision neuromodulation techniques are redefining what's possible for neurological recovery, and the National Institutes of Health (NIH) has made a substantial investment to support the ...